Bristol-Myers: 'have made a full and fair offer' for ImClone
Bristol-Myers Squibb Co. believes it has made a ``full and fair offer'' to acquire full ownership of ImClone Systems Inc., a spokeswoman said Monday in response to ImClone's statement that the bid undervalues ImClone.
iMedicor today announced it has signed an agreement with Dallas-based Access Pharmaceuticals for the North American commercial launch of MuGard, its FDA-approved oral wound rinse for the management of oral mucositis and stomatitis caused by radiotherapy and/or chemotherapy.